SELE
Basic information
Region (hg38): 1:169722640-169764705
Previous symbols: [ "ELAM1", "ELAM" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SELE gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 4 | |||||
missense | 33 | 38 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 2 | |||||
Total | 0 | 0 | 34 | 3 | 7 |
Variants in SELE
This is a list of pathogenic ClinVar variants found in the SELE region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-169725794-G-C | not specified | Uncertain significance (Mar 11, 2022) | ||
1-169726704-C-T | not specified | Uncertain significance (Jun 22, 2024) | ||
1-169726717-G-A | not specified | Uncertain significance (Dec 21, 2023) | ||
1-169726729-G-A | Coronary artery disorder | Benign (May 12, 2022) | ||
1-169726764-G-C | not specified | Uncertain significance (Jun 01, 2023) | ||
1-169726804-G-A | Uncertain significance (Mar 30, 2021) | |||
1-169727411-C-T | not specified | Uncertain significance (Dec 13, 2023) | ||
1-169727474-C-T | not specified | Uncertain significance (Mar 31, 2024) | ||
1-169727504-G-A | not specified | Uncertain significance (Dec 18, 2023) | ||
1-169727805-G-A | IgA nephropathy, susceptibility to | Uncertain significance (Jan 01, 2006) | ||
1-169727817-C-G | not specified | Uncertain significance (Sep 16, 2021) | ||
1-169727828-C-G | not specified | Uncertain significance (Jan 26, 2022) | ||
1-169727892-C-T | not specified | Uncertain significance (Jul 26, 2021) | ||
1-169727912-G-C | not specified | Uncertain significance (Feb 26, 2024) | ||
1-169728076-C-G | Benign (Dec 31, 2019) | |||
1-169728077-G-A | Benign (Jun 29, 2018) | |||
1-169728090-C-G | not specified | Uncertain significance (Apr 04, 2024) | ||
1-169728109-G-A | not specified | Uncertain significance (Nov 18, 2022) | ||
1-169728127-A-G | Benign (Apr 10, 2018) | |||
1-169728213-C-T | not specified | Uncertain significance (Dec 15, 2023) | ||
1-169729245-G-T | not specified | Uncertain significance (Feb 27, 2023) | ||
1-169729301-G-T | Uncertain significance (Mar 30, 2021) | |||
1-169729309-C-T | not specified | Uncertain significance (Mar 27, 2023) | ||
1-169729344-T-C | not specified | Uncertain significance (Jan 17, 2024) | ||
1-169729479-C-A | Uncertain significance (Mar 30, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SELE | protein_coding | protein_coding | ENST00000333360 | 12 | 42066 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
7.91e-10 | 0.972 | 125676 | 0 | 62 | 125738 | 0.000247 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.125 | 333 | 327 | 1.02 | 0.0000160 | 4004 |
Missense in Polyphen | 80 | 104.34 | 0.7667 | 1349 | ||
Synonymous | 0.188 | 118 | 121 | 0.978 | 0.00000642 | 1123 |
Loss of Function | 2.20 | 20 | 33.8 | 0.592 | 0.00000152 | 409 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000330 | 0.000329 |
Ashkenazi Jewish | 0.000112 | 0.0000992 |
East Asian | 0.000934 | 0.000925 |
Finnish | 0.0000465 | 0.0000462 |
European (Non-Finnish) | 0.000248 | 0.000246 |
Middle Eastern | 0.000934 | 0.000925 |
South Asian | 0.000196 | 0.000196 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Cell-surface glycoprotein having a role in immunoadhesion. Mediates in the adhesion of blood neutrophils in cytokine-activated endothelium through interaction with SELPLG/PSGL1. May have a role in capillary morphogenesis. {ECO:0000269|PubMed:1689848, ECO:0000269|PubMed:28011641}.;
- Pathway
- Cell adhesion molecules (CAMs) - Homo sapiens (human);AGE-RAGE signaling pathway in diabetic complications - Homo sapiens (human);African trypanosomiasis - Homo sapiens (human);TNF signaling pathway - Homo sapiens (human);Malaria - Homo sapiens (human);Fluid shear stress and atherosclerosis - Homo sapiens (human);TNF alpha Signaling Pathway;Human Complement System;Photodynamic therapy-induced NF-kB survival signaling;VEGFA-VEGFR2 Signaling Pathway;ATF-2 transcription factor network;Glucocorticoid receptor regulatory network;Cell surface interactions at the vascular wall;Hemostasis;Thromboxane A2 receptor signaling
(Consensus)
Recessive Scores
- pRec
- 0.535
Intolerance Scores
- loftool
- 0.837
- rvis_EVS
- 1.33
- rvis_percentile_EVS
- 94.22
Haploinsufficiency Scores
- pHI
- 0.0818
- hipred
- N
- hipred_score
- 0.147
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.691
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Sele
- Phenotype
- vision/eye phenotype; immune system phenotype; liver/biliary system phenotype; respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; growth/size/body region phenotype; cellular phenotype; homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- positive regulation of receptor internalization;leukocyte migration involved in inflammatory response;inflammatory response;heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules;leukocyte cell-cell adhesion;activation of phospholipase C activity;calcium-mediated signaling;actin filament-based process;response to lipopolysaccharide;response to tumor necrosis factor;regulation of inflammatory response;leukocyte migration;leukocyte tethering or rolling;response to interleukin-1
- Cellular component
- extracellular space;plasma membrane;integral component of plasma membrane;caveola;clathrin-coated pit;cortical cytoskeleton;membrane raft;perinuclear region of cytoplasm
- Molecular function
- transmembrane signaling receptor activity;protein binding;sialic acid binding;phospholipase binding;metal ion binding;oligosaccharide binding